Cargando…

Molecular Biomarkers in Glioblastoma: A Systematic Review and Meta-Analysis

Background: Glioblastoma (GBM) is a highly aggressive cancer with poor prognosis that needs better treatment modalities. Moreover, there is a lack of reliable biomarkers to predict the response and outcome of current or newly designed therapies. While several molecular markers have been proposed as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sareen, Heena, Ma, Yafeng, Becker, Therese M., Roberts, Tara L., de Souza, Paul, Powter, Branka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408540/ https://www.ncbi.nlm.nih.gov/pubmed/36012105 http://dx.doi.org/10.3390/ijms23168835

Ejemplares similares

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients
por: Sareen, Heena, et al.
Publicado: (2020)

Prognostic and Predictive Value of CCND1/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis
por: Jeffreys, Sarah A., et al.
Publicado: (2022)

From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients
por: Grebstad Tune, Benedicte, et al.
Publicado: (2023)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Khan, Tanzila, et al.
Publicado: (2022)

Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome
por: Garrett, Celine, et al.
Publicado: (2021)

Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR
por: Young, Francis P., et al.
Publicado: (2022)

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy
por: Fatima, Shadma, et al.
Publicado: (2022)

Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers
por: Khan, Tanzila, et al.
Publicado: (2022)

Molecular and Circulating Biomarkers in Patients with Glioblastoma
por: Senhaji, Nadia, et al.
Publicado: (2022)

The Multiple Potential Biomarkers for Predicting Immunotherapy Response—Finding the Needle in the Haystack
por: Adam, Tamiem, et al.
Publicado: (2021)

The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma
por: Marivel, A-M Joëlle, et al.
Publicado: (2023)

Imaging Biomarkers of Glioblastoma Treatment Response: A Systematic Review and Meta-Analysis of Recent Machine Learning Studies
por: Booth, Thomas C., et al.
Publicado: (2022)

Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status
por: Po, Joseph W., et al.
Publicado: (2019)

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?
por: Khan, Tanzila, et al.
Publicado: (2020)

Erratum: Imaging biomarkers of glioblastoma treatment response: a systematic review and meta-analysis of recent machine learning studies
Publicado: (2023)

Impact of molecular and clinical variables on survival outcome with immunotherapy for glioblastoma patients: A systematic review and meta‐analysis
por: Hu, Wentao, et al.
Publicado: (2022)

Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
por: del Pino-Sedeño, Tasmania, et al.
Publicado: (2022)

Molecular Pathogenesis of Glioblastoma in Adults and Future Perspectives: A Systematic Review
por: Esemen, Yagmur, et al.
Publicado: (2022)

Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis
por: Xiao, Zhi-Ze, et al.
Publicado: (2020)

Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies
por: Ma, Yafeng, et al.
Publicado: (2016)

Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
por: Trone, Jane-Chloe, et al.
Publicado: (2020)

Radiotherapy for glioblastoma in the elderly: A protocol for systematic review and meta-analysis
por: Huang, Puxin, et al.
Publicado: (2020)

Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis
por: Wahyuhadi, Joni, et al.
Publicado: (2022)

Cystic glioblastoma: A systematic review and meta-analysis of characteristics and outcomes
por: Sae-Huang, Morrakot, et al.
Publicado: (2022)

Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review
por: Su, Jiahao, et al.
Publicado: (2016)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer
por: Wilkinson, Kate, et al.
Publicado: (2021)

Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis
por: Zhang, John J Y, et al.
Publicado: (2020)

The Prognostic Effect of Dexamethasone on Patients With Glioblastoma: A Systematic Review and Meta-Analysis
por: Zhou, Lingling, et al.
Publicado: (2021)

Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
por: Revilla-Pacheco, Francisco, et al.
Publicado: (2021)

Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma
por: Li, Mingdong, et al.
Publicado: (2019)

Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA
por: Yang, Qi, et al.
Publicado: (2018)

Emerging Biomarkers in Glioblastoma
por: McNamara, Mairéad G., et al.
Publicado: (2013)

lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis
por: Zheng, Chuqian, et al.
Publicado: (2017)

COVID-2019–2020–2021: Systematic Review and Meta-Analysis
por: Reddy, S. Ganesh Kumar, et al.
Publicado: (2021)

Tolerability of Ziprasidone Use in Children and Adolescents: A Prisma Model: Systematic Review and Meta-Analysis
por: Jay, J., et al.
Publicado: (2022)

Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma
por: Schritz, Anna, et al.
Publicado: (2021)

Surgery vs. Biopsy in the Treatment of Butterfly Glioblastoma: A Systematic Review and Meta-Analysis
por: Chawla, Shreya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5apikfud3pnr1l4lrsnlp8ba76